GlycoMimetics Inc (GLYC)

0.2364 -0.02 (-7.44%) USD  |  NASDAQ  |  Dec 27, 16:00
0.2386 0.00 (0.00%) After-Hours: 20:00
More

GlycoMimetics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp Upgrade
Revance Therapeutics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade